CD8A and neoplasm: To better assess other potential sources of the requisite TCR activation, we first performed in vitro cytotoxicity experiments by mixing CD8+ T cells with both MHC-I-positive and MHC-I-negative tumor cells, eliminating macrophages from the culture.